Novo Nordisk Insulin Levemir Gets Approved for Diabetes in Japan (Japan)
This article was originally published in PharmAsia News
Executive Summary
Levemir, a drug produced by Danish pharmaceutical company, Novo Nordisk, has been approved in Japan. Following the approval, Novo announced its plans to begin marketing the drug for type one and type two diabetes in Japan before the end of 2007. (Click here for more